1-1 of 1
Patricia Wendling, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Molecular Response At 3 Months Can Identify Three Groups Of Patients With Different Responses and Event-Free Survival At 36-Months Following Second-Generation Tyrosine Kinase Inhibitor Therapy In Imatinib-Resistant Chronic Myeloid Leukemia

Carla Boquimpani, MD, Rony Schaffel, MD, PhD, Daniel Graça, Camila Mesquita, Tania Silva Madeira, MD, Danielle Peixoto, MD, Patricia Wendling, MD, Clarisse Lobo, MD, Irene Biasoli, MD, PhD, Nelson Spector, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4005.
https://doi.org/10.1182/blood.V122.21.4005.4005
Published: 2013